{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:56:06Z","timestamp":1789736166191,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.psym.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T15:30:58Z","timestamp":1356017458000},"page":"387-391","source":"Crossref","is-referenced-by-count":21,"title":["Dopamine Agonist-Induced Impulse Control Disorders in a Patient with Prolactinoma"],"prefix":"10.1016","volume":"54","author":[{"given":"Santiago","family":"Almanzar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Zapata-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psym.2012.10.002_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0317167100010489","article-title":"Outcomes of patients with Parkinson disease and pathological gambling","volume":"37","author":"Bharmal","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.psym.2012.10.002_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case-control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.psym.2012.10.002_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WNF.0b013e31820d6699","article-title":"The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome","volume":"34","author":"Dang","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psym.2012.10.002_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2377-11-117","article-title":"Frequency of impulse control behaviors associated with dopaminergic therapy in restless legs syndrome","volume":"11","author":"Voon","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.psym.2012.10.002_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10899-009-9123-2","article-title":"Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia","volume":"25","author":"Holman","year":"2009","journal-title":"J Gambl Stud"},{"key":"10.1016\/j.psym.2012.10.002_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.psym.2012.10.002_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/appi.neuropsych.20.4.496","article-title":"Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy","volume":"20","author":"Kim","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psym.2012.10.002_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mds.22902","article-title":"Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy","volume":"25","author":"O'Sullivan","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.psym.2012.10.002_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.psym.2012.10.002_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.psym.2012.10.002_bib12","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","article-title":"Prevalence of Pathological gambling in patients with Parkinson's disease","volume":"21","author":"Avanzi","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.psym.2012.10.002_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psym.2012.10.002_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.neuropsych.19.4.473","article-title":"Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma","volume":"19","author":"Davie","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psym.2012.10.002_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5694\/j.1326-5377.2009.tb02289.x","article-title":"Pathological gambling and hypersexuality in cabergoline treated prolactinoma","volume":"190","author":"Falhammar","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.psym.2012.10.002_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0031-1281580","article-title":"Pathological gambling induced by dopamine agonists","volume":"79","author":"Gahr","year":"2011","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.psym.2012.10.002_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","article-title":"Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas","volume":"34","author":"Martinkova","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psym.2012.10.002_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrendo.2011.37","article-title":"Medical treatment of prolactinomas","volume":"7","author":"Colao","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.psym.2012.10.002_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0033-3182(10)70718-0","article-title":"Management of psychosis associated with a prolactinoma: case report and review of the literature","volume":"51","author":"Ali","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psym.2012.10.002_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.genhosppsych.2007.11.002","article-title":"Cabergoline-induced psychotic exacerbation in schizophrenic patients","volume":"30","author":"Chang","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.psym.2012.10.002_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psym.2012.10.002_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1755-5922.2010.00169.x","article-title":"Regression of cardiac valvulopathy related to ergot-derived dopamine agonists","volume":"29","author":"Zanettini","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.psym.2012.10.002_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2550-7","article-title":"Similarities and differences between Pathological gambling and substance use disorders: a focus on impulsivity and compulsivity","volume":"219","author":"Leeman","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psym.2012.10.002_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12152-010-9071-7","article-title":"Drug-induced impulse control disorders: a prospectus for neuroethical analysis","volume":"4","author":"Carter","year":"2010","journal-title":"Neuroethics"},{"key":"10.1016\/j.psym.2012.10.002_bib25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.psym.2012.10.002_bib26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psym.2012.10.002_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.06.074","article-title":"Impulse control disorders in Parkinson's disease in a Chinese population","volume":"465","author":"Fan","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.psym.2012.10.002_bib28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1037\/a0023795","article-title":"The risky business of dopamine agonists in Parkinson disease and impulse control disorders","volume":"125","author":"Claassen","year":"2011","journal-title":"Behav Neurosci"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318212001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318212001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T21:56:41Z","timestamp":1643925401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318212001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0033318212001843"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2012.10.002","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}